Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Jun 14, 2016; 22(22): 5246-5253
Published online Jun 14, 2016. doi: 10.3748/wjg.v22.i22.5246
Table 1 Baseline demographic and clinical characteristics of patients undergoing esophagectomy n (%)
CharacteristicGroup 1Group 2Group 3P value
No complicationPre-discharge complicationPost-discharge complication
n = 2497 (55.70)n = 1588 (35.42)n = 398 (8.88)
Age, mean (median)62.5 ± 11.2 (63)63.9 ± 10.8 (65)63.4 ± 10.9 (64)0.001
Age group (yr)0.048
< 60921 (36.88)513 (32.30)143 (35.93)
60-69862 (34.52)579 (36.46)126 (31.66)
70-79602 (24.11)407 (25.63)109 (27.39)
≥ 80112 (4.49)89 (5.60)20 (5.03)
Male12042 (81.88)1220 (76.83)325 (81.66)< 0.001
Race0.088
White2135 (85.50)1363 (85.83)352 (88.44)
Black76 (3.04)62 (3.90)6 (1.51)
Other/unknown286 (11.45)168 (10.26)40 (10.05)
ASA classification1< 0.001
No disturb/mild disturb611 (24.50)237 (14.92)88 (22.17)
Serious disturb1746 (70.01)1161 (73.11)269 (67.76)
Life threat/moribund137 (5.49)190 (11.96)40 (10.08)
Body mass index, mean (median)27.9 ± 6.4 (27)27.7 ± 6.3 (26.9)28.4 ± 6.2 (27.6)0.132
Body mass index group1 (kg/m2)0.013
< 18.568 (2.75)59 (3.75)9 (2.26)
18.5-24.9761 (30.72)522 (33.14)100 (25.13)
25-29.9905 (36.54)532 (33.78)159 (39.95)
≥ 30743 (30.00)462 (29.33)130 (32.66)
Diabetes341 (13.66)300 (18.89)75 (18.84)< 0.001
Current smoker616 (24.67)434 (27.33)86 (21.61)0.033
Dyspnea209 (8.37)205 (12.91)48 (12.06)< 0.001
History of COPD131 (5.25)156 (9.82)23 (5.78)< 0.001
Weight loss468 (18.74)301 (18.95)73 (18.34)0.959
Steroid use74 (2.96)42 (2.64)12 (3.02)0.820
Emergency case18 (0.72)39 (2.46)3 (0.75)< 0.001
Diagnosis0.002
Benign disease355 (14.22)289 (18.20)56 (14.07)
Esophageal/gastric cancer2142 (85.78)1299 (81.80)342 (85.93)
Year of operation0.012
2005-2007293 (11.73)223 (14.04)41 (10.30)
2008-2010746 (29.88)409 (25.76)109 (27.39)
2011-20131458 (58.39)956 (60.20)248 (62.31)
Table 2 Observed unadjusted rates of pre- and post-discharge outcomes after esophagectomy n (%)
OutcomeTotal (n = 1986)Group 2Group 3P value
Pre-discharge complicationPost-discharge complication
n = 1588 (79.96)n = 398 (20.04)
30-d mortality1140 (7.05)104 (6.55)36 (9.05)0.082
Overall morbidity
Wound infection470 (23.67)307 (19.33)163 (40.95)< 0.001
Pneumonia535 (26.94)444 (27.96)91 (22.86)0.040
Urinary tract infection112 (5.64)91 (5.73)21 (5.28)0.725
Venous thromboembolism207 (10.42)142 (8.94)65 (16.33)< 0.001
Cardiac complication108 (5.44)92 (5.79)16 (4.02)0.163
Shock/sepsis518 (26.08)422 (26.57)96 (24.12)0.319
Unplanned intubation420 (21.15)368 (23.17)52 (13.07)< 0.001
Bleeding transfusion584 (29.41)526 (33.12)58 (14.57)< 0.001
Renal complication59 (2.97)50 (3.15)9 (2.26)0.351
On ventilator > 48 h439 (22.10)396 (24.94)43 (10.80)< 0.001
Organ space SSI242 (12.19)174 (10.96)68 (17.09)0.001
Reoperation 12-13235 (25.97)160 (22.38)75 (39.47)< 0.001
Serious Morbidity21102 (55.49)901 (56.74)201 (50.50)0.025
Year of operation0.142
2005-2007264 (13.29)223 (14.04)41 (10.30)
2008-2010518 (26.08)409 (25.76)109 (27.39)
2011-20131204 (60.62)956 (60.20)248 (62.31)
Length of stay, d (median)11.7 ± 5.4 (10)15.0 ± 6.3 (14)10.3 ± 4.3 (9)< 0.001
Prolonged length of stay3765 (38.52)707 (44.52)58 (14.57)< 0.001
Operative time, min (median)342.3 ± 134.7 (328)358.6 ± 145.6 (343)350.4 ± 133.1 (335.5)0.308
Prolonged operative time4570 (28.70)467 (29.41)103 (25.88)0.164
Readmission 2011-2013226 (19.07)62 (6.60)164 (66.94)< 0.001
Table 3 Unadjusted risk and risk ratio for post-discharge complications after esophagectomy
Risk factorPDC risk (n/total)RR (95%CI)
Overall PDC risk398/4379 (9.09)-
Procedure type
Ivor-Lewis196/2219 (8.83)Ref
Transhiatal115/1261 (9.12)1.03 (0.83-1.29)
3-holes66/730 (9.04)1.02 (0.78-1.34)
Intestinal conduit21/169 (12.43)1.41 (0.92-2.15)
Age group (%)
< 60143/1562 (9.15)Ref
60-69126/1529 (8.24)0.90 (0.72-1.13)
70-79109/1082 (10.07)1.10 (0.87-1.39)
≥ 8020/206 (9.71)1.06 (0.68-1.65)
Male (%)325/3505 (9.27)1.11 (0.87-1.41)
Race (%)
White352/3763 (9.35)Ref
Black6/137 (4.38)0.46 (0.21-1.00)
Other/unknown40/479 (8.35)0.89 (0.65-1.22)
ASA classification (%)
No disturb/mild disturb88/930 (9.46)Ref
Serious disturb269/3104 (8.67)0.92 (0.73-1.15)
Life threat/moribund40/341 (11.73)1.24 (0.87-1.76)
Body mass index (%)
18.5-24.9100/1347 (7.42)Ref
< 18.59/129 (6.98)0.94 (0.49-1.81)
25-29.9159/1561 (10.19)1.37 (1.08-1.74)
≥ 30130/1310 (9.92)1.34 (1.04-1.72)
Diabetes (%)75/692 (10.84)1.24 (0.98-1.57)
Current smoker (%)86/1111 (7.74)0.81 (0.64-1.02)
Dyspnea (%)48/436 (11.01)1.24 (0.93-1.65)
History of COPD (%)23/297 (7.74)0.84 (0.56-1.26)
Weight loss (%)73/812 (8.99)0.99 (0.77-1.26)
Steroid use (%)12/124 (9.68)1.07 (0.62-1.84)
Emergency case3/52 (5.77)0.63 (0.21-1.90)
Esophageal/gastric cancer (%)342/3707 (9.23)1.11 (0.84-1.45)
Prolonged length of stay1 (%)58/938 (6.18)0.63 (0.48-0.82)
Prolonged operative time2 (%)103/1087 (9.48)1.06 (0.85-1.31)